Patexia Research

Case number 1:24-cv-01408

Lawsuits

Novartis Pharmaceuticals Corporation v. Umedica Laboratories Pvt. Ltd. > Summary

Court Case Number 1:24-cv-01408

Filing Date Dec 23, 2024

Termination Date Jan 2, 2025

Court Delaware District Court

Status Dismissed - Other

Plaintiff

Defendant

Umedica Laboratories Pvt. Ltd

Related Patents

Doc No	Title	Issue date
11135192	Inhibitors for treating diseases characterized by atrial enlargement or remodeling	Oct 5, 2021
11096918	Amorphous solid form of compounds containing S--N-valeryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations	Aug 24, 2021
11058667	Sacubitril-valsartan dosage regimen for treating heart failure	Jul 13, 2021
09937143	Inhibitors for treating diseases characterized by atrial enlargement or remodeling	Apr 10, 2018
09517226	Inhibitors for treating diseases characterized by atrial enlargement or remodeling	Dec 13, 2016
09388134	Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations	Jul 12, 2016
08877938	Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations	Nov 4, 2014
08101659	Methods of treatment and pharmaceutical composition	Jan 24, 2012